NCT06137794View on ClinicalTrials.gov

"Application of I-Anticoagulationin Patients With Atrial Fibrillation"

NANot yet recruitingINTERVENTIONAL

Enrollment

440

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions

Atrial FibrillationAnticoagulants

Interventions

OTHER

"Use of I-Anticoagulation to make the decision and manage patients"

I-Anticoagulation will offer a flexible and efficient communication platform for healthcare professionals and AF patients. The tool is composed of two modules: an anticoagulation decision support system and a full-process patient management system.

All Listed Sponsors

lead

RenJi Hospital

OTHER

NCT06137794 - "Application of I-Anticoagulationin Patients With Atrial Fibrillation" | Biotech Hunter | Biotech Hunter